Identification of a serum biomarker signature associated with metastatic prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Identification of a serum biomarker signature associated with metastatic prostate cancer ; day:04 ; month:05 ; year:2021 ; extent:13
Proteomics / Clinical applications. Clinical applications ; (04.05.2021) (gesamt 13)
- Creator
-
Kuci Emruli, Venera
Liljedahl, Leena
Axelsson, Ulrika
Richter, Corinna
Theorin, Lisa
Bjartell, Anders
Lilja, Hans
Donovan, Jenny
Neal, David
Hamdy, Freddie C.
Borrebaeck, Carl A. K.
- DOI
-
10.1002/prca.202000025
- URN
-
urn:nbn:de:101:1-2021050515020057807986
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kuci Emruli, Venera
- Liljedahl, Leena
- Axelsson, Ulrika
- Richter, Corinna
- Theorin, Lisa
- Bjartell, Anders
- Lilja, Hans
- Donovan, Jenny
- Neal, David
- Hamdy, Freddie C.
- Borrebaeck, Carl A. K.
Other Objects (12)
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer
Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma
A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature
MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer
A targeted antibody-based array reveals a serum protein signature as biomarker for adolescent idiopathic scoliosis patients
A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer
Future therapeutic strategies for metastatic prostate cancer
Leptomeningeal Carcinomatosis of Metastatic Primary Prostate Cancer
A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas
Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients
Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer
Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma
A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature
MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer
A targeted antibody-based array reveals a serum protein signature as biomarker for adolescent idiopathic scoliosis patients
A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer
Future therapeutic strategies for metastatic prostate cancer
Leptomeningeal Carcinomatosis of Metastatic Primary Prostate Cancer
A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas
Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients
Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer
Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma
A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature
MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer
A targeted antibody-based array reveals a serum protein signature as biomarker for adolescent idiopathic scoliosis patients
A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer
Future therapeutic strategies for metastatic prostate cancer
Leptomeningeal Carcinomatosis of Metastatic Primary Prostate Cancer
A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas
Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients